ConductScience.org, home

Paper29344179

In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model.

Si C and 7 others. Oncol Lett, 2017. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model. Papers, record 29344179. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29344179

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model.
PubMed
Journal
Oncol Lett
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2020-09-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Si CChunfeng
2Xu MMaolei
3Lu MMeiyu
4Yu YYan
5Yang MMeizi
6Yan MMiaomiao
7Zhou LLing
8Yang XXiaoping

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120653081A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer.Vaccine2010https://conductscience.org/library/papers/20653081PubMed
223428946Adjuvant GM-CSF improves survival in high-risk stage iiic melanoma: a single-center Study.Am J Clin Oncol2014https://conductscience.org/library/papers/23428946PubMed
321321245Vaccination with OK-432 followed by TC-1 tumor lysate leads to significant antitumor effects.Reprod Sci2011https://conductscience.org/library/papers/21321245PubMed
423456765Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.Tumour Biol2013https://conductscience.org/library/papers/23456765PubMed
523261248Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways.J Biomech2013https://conductscience.org/library/papers/23261248PubMed
625981111Specific cellular immune response elicited by the necrotic tumor cell-stimulated macrophages.Int Immunopharmacol2015https://conductscience.org/library/papers/25981111PubMed
717420942A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.Dig Dis Sci2007https://conductscience.org/library/papers/17420942PubMed
824101126Intradermal immunization with combined baculovirus and tumor cell lysate induces effective antitumor immunity in mice.Int J Oncol2013https://conductscience.org/library/papers/24101126PubMed
917980936Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.Vaccine2007https://conductscience.org/library/papers/17980936PubMed
1026221228The tumor protection effect of high-frequency administration of whole tumor cell vaccine and enhanced efficacy by the protein component from Agrocybe aegerita.Int J Clin Exp Med2015https://conductscience.org/library/papers/26221228PubMed
1121761245Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine.Med Oncol2012https://conductscience.org/library/papers/21761245PubMed
1220838433Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.PLoS One2010https://conductscience.org/library/papers/20838433PubMed
1322971679Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma.Int J Oncol2012https://conductscience.org/library/papers/22971679PubMed
1419394651Anti-angiogenic therapy on hepatocellular carcinoma development and progression.J Surg Res2010https://conductscience.org/library/papers/19394651PubMed
1510207881Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene.Nat Biotechnol1999https://conductscience.org/library/papers/10207881PubMed
1614643445Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma model.Cancer Lett2003https://conductscience.org/library/papers/14643445PubMed
1725310154Tumor cell lysate induces the immunosuppression and apoptosis of mouse immunocytes.Mol Med Rep2014https://conductscience.org/library/papers/25310154PubMed
1817242926Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine.Cancer Immunol Immunother2007https://conductscience.org/library/papers/17242926PubMed
1923528346Liver cancer: The promise of new approaches in the management of hepatocellular carcinoma--adding to the toolbox?Nat Rev Gastroenterol Hepatol2013https://conductscience.org/library/papers/23528346PubMed
2024357284Breakthrough of the year 2013. Cancer immunotherapy.Science2013https://conductscience.org/library/papers/24357284PubMed

See all 24 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41810102Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy.J Clin Transl Hepatol2026https://conductscience.org/library/papers/41810102PubMed
39853538Immunomodulatory activity of Trypanosoma cruzi recombinant antigen combination TSA-1-C4 and Tc24-C4 induce activation of macrophages and CD8+ T cells.Parasitol Res2025https://conductscience.org/library/papers/39853538PubMed
38206300Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma.Aging (Albany NY)2024https://conductscience.org/library/papers/38206300PubMed
37631925A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma.Vaccines (Basel)2023https://conductscience.org/library/papers/37631925PubMed
35457221Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions.Int J Mol Sci2022https://conductscience.org/library/papers/35457221PubMed
32899197Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32899197PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29344179

GET https://conductscience.org/api/papers/v1/29344179/references?page=2